Amacanin, Princess B.
HRN: 02-11-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2024
CEFUROXIME 1.5GM (VIAL)
01/18/2024
01/25/2024
IV
1.5 G
Every 8 Hours
Internal Hemorrhoids
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes